Corrigendum: Hyperglycemia and Risk of All-cause Mortality Among People Living With HIV With and Without Tuberculosis Disease in Myanmar (2011–2017)

In Figure 1, “ǂ” in the box should be labeled “a” and two “*” in the box should be labeled “b”. In Figure 2, the second row under the “Number at risk” should read “Hyperglycemia” in all A, B, and C of the figure.

Figure 1.

Flow diagram of patients included in the study stratified by their comorbidity with tuberculosis (TB) status and outcomes among people living with HIV registered in HIV clinics in Myanmar between 2011 and 2016. aPatients with TB disease include both prevalent TB at the time of registration to the program and incident TB developed during follow-up. bTransferred out to other programs to continue care. Abbreviations: IPT, isoniazid preventive therapy; RBG, random blood glucose.

Figure 2.

Nelson-Aalen plots of cumulative mortality stratified by hyperglycemia status (A) among all people living with HIV (PLHIV), (B) among PLHIV with tuberculosis (TB) disease, and (C) among PLHIV without TB disease enrolled in the Integrated HIV Care program in Myanmar between 2011 and 2017. Abbreviation: CI, confidence interval.